Order results by:
| Issue | Title | |
| Vol 4, No 3 (2012) | Clinical experience with requip modutab | Abstract similar documents |
| Denis Valeryevich Zakharov, V A Mikhailov | ||
| "... dyskinesias. Controlled-release DRAs are of particular interest. The results of using requip modutab in PD ..." | ||
| Vol 5, No 1 (2013) | Practical aspects of the use of extended-release ropinirole (requip modutab) in the treatment of Parkinson’s disease | Abstract similar documents |
| Oleg Semenovich Levin, V K Datiyeva | ||
| "... for many years. The efficiency of extended-release ropinirole (Requip Modutab) was evaluated in 12 patients ..." | ||
| Vol 4, No 2 (2012) | Capacities of the dopamine receptor agonist pramipexole in the treatment of patients with Parkinson’s disease | Abstract similar documents |
| S N Illarioshkin | ||
| "... receptor agonists (DRA) remains the leading pharmacotherapeutic strategy for Parkinson’s disease (PD ..." | ||
| Vol 6, No 3 (2014) | Current therapy for Parkinson's disease | Abstract similar documents |
| A. V. Obukhova | ||
| "... in the nigrostriatal system. Levodopa preparations and dopamine receptor agonists (DRAs) that are prescribed ..." | ||
| Vol 5, No 3 (2013) | The efficacy of the dopamine agonist Rotigotine in the treatment of Parkinson's disease | Abstract similar documents |
| Marina Romanovna Nodel | ||
| "... Rotigotine is a new, non-ergot dopamine receptor agonist (DRA) formulated as a transdermal drug ..." | ||
| Vol 16, No 3 (2024) | Treatment of the early stages of Parkinson's disease. Differences in approaches to the choice of therapy in different countries | Abstract similar documents |
| E. V. Bril, N. V. Fedorova, T. K. Kulua, O. S. Zimnyakova | ||
| "... country, dopamine receptor agonists (DRAs) are currently one of the most commonly prescribed groups ..." | ||
| Vol 15, No 3 (2023) | Parkinson’s disease. Focus on early stages | Abstract similar documents |
| E. A. Katunina, Z. A. Zalyalova, D. V. Pokhabov, M. Z. Ivanova, A. M. Semenova | ||
| "... леводопы, более молодым пациентам – сагонистов дофаминовых рецепторов (АДР), амантадинов, ингибиторов МАО-В ..." | ||
| Vol 16, No 2 (2024) | Efficacy of antiparkinsonian therapy in tremor correction according to tremorography | Abstract similar documents |
| V. A. Bogacheva, D. V. Zakharov, V. A. Mikhailov | ||
| "... препаратов в монотерапии: агонисты дофаминовых рецепторов (АДР; прамипексол), препараты леводопы (Тидомет ..." | ||
| Vol 15, No 6 (2023) | Effect of dopaminergic therapy on lacrimation in Parkinson's disease | Abstract similar documents |
| A. A. Pilipovich, O. V. Vorob'eva, S. A. Makarov, A. V. Kuchuk | ||
| "... ), агонистами дофаминовых рецепторов (АДР; n=28), они были обследованы с использованием теста Ширмера для ..." | ||
| 1 - 9 of 9 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
